Long-Acting Injectable (LAI) Aripiprazole Formulations in the Treatment of Schizophrenia and Bipolar Disorder: a Systematic Review-Reference-Cited by-同舟云学术

Long-Acting Injectable (LAI) Aripiprazole Formulations in the Treatment of Schizophrenia and Bipolar Disorder: a Systematic Review

Published:2019-05-31 Issue:8 Volume:39 Page:713-735
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clin Drug Investig

Author:

Rapinesi Chiara,Kotzalidis Georgios D.^ORCID,Mazzarini Lorenzo,Brugnoli Roberto,Ferracuti Stefano,De Filippis Sergio,Cuomo Ilaria,Giordano Gloria,Del Casale Antonio,Angeletti Gloria,Sani Gabriele,Girardi Paolo

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s40261-019-00801-9.pdf

Reference61 articles.

1. Stevens GL, Dawson G, Zummo J. Clinical benefits and impact of early use of long-acting injectable antipsychotics for schizophrenia. Early Interv Psychiatry. 2016;10(5):365–77.

2. Leucht S, Heres S. Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia. J Clin Psychiatry. 2006;67(Suppl 5):3–8.

3. Leucht C, Heres S, Kane JM, Kissling W, Davis JM, Leucht S. Oral versus depot antipsychotic drugs for schizophrenia-a critical systematic review and meta-analysis of randomised long-term trials. Schizophr Res. 2011;127(1–3):83–92.

4. Amano T, Matsubayashi H, Momiyama T, Ishihara K, Todo N, Sasa M. Antagonizing effects of a novel antipsychotic quinolinone derivative (OPC-14597) on dopaminergic inhibition of neuronal activities in the nucleus accumbens. Prog Neuropsychopharmacol Biol Psychiatry. 1995;19(1):105–16.

5. Fujikawa M, Nagashima M, Inoue T, Yamada K, Furukawa T. Partial agonistic effects of OPC-14597, a potential antipsychotic agent, on yawning behavior in rats. Pharmacol Biochem Behav. 1996;53(4):903–9.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A case report of LAI two injection start in a 16-year-old adolescent with severe manic episode and comorbid cannabinoid use disorder;Asian Journal of Psychiatry;2024-04

2. Impact of long-acting injectable aripiprazole on the concomitant medication and antipsychotic polypharmacy: a retrospective, observational study of 127 patients with psychosis;International Clinical Psychopharmacology;2023-11-20

3. Aripiprazole for the treatment of schizophrenia: Recommendations of a panel of Spanish experts on its use in clinical practice;International Journal of Psychiatry in Clinical Practice;2022-07-06

4. P.0407 Follow-up study on long‐acting injectable antipsychotics on bipolar disorder at a portuguese inpatient psychiatric unit (Hospital Egas Moniz);European Neuropsychopharmacology;2021-12

5. Aripiprazole IM depot as an option for the treatment of bipolar disorder;Expert Opinion on Pharmacotherapy;2021-04-13